For the second time in a month, Davis Polk & Wardwell represented Irish drugmaker Warner Chilcott in a billion-dollar deal. This time, however, Warner is the seller, not the buyer.

A few weeks ago, Davis Polk advised Warner on the company’s $3.1 billion acquisition of Procter & Gamble’s pharmaceutical business, a bigger-than-expected deal that required Warner to secure $4 billion in financing from six banks.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]